228 related articles for article (PubMed ID: 25220405)
1. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism.
Blakeslee WW; Wysoczynski CL; Fritz KS; Nyborg JK; Churchill ME; McKinsey TA
Cell Signal; 2014 Dec; 26(12):2912-20. PubMed ID: 25220405
[TBL] [Abstract][Full Text] [Related]
2. A SUMO-acetyl switch in PXR biology.
Cui W; Sun M; Zhang S; Shen X; Galeva N; Williams TD; Staudinger JL
Biochim Biophys Acta; 2016 Sep; 1859(9):1170-1182. PubMed ID: 26883953
[TBL] [Abstract][Full Text] [Related]
3. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
Wagner T; Godmann M; Heinzel T
Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
[TBL] [Abstract][Full Text] [Related]
5. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.
Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA
J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211
[TBL] [Abstract][Full Text] [Related]
6. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
7. HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2.
Scognamiglio A; Nebbioso A; Manzo F; Valente S; Mai A; Altucci L
Biochim Biophys Acta; 2008 Oct; 1783(10):2030-8. PubMed ID: 18691615
[TBL] [Abstract][Full Text] [Related]
8. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.
Zhao X; Sternsdorf T; Bolger TA; Evans RM; Yao TP
Mol Cell Biol; 2005 Oct; 25(19):8456-64. PubMed ID: 16166628
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function.
Cong L; Pakala SB; Ohshiro K; Li DQ; Kumar R
J Biol Chem; 2011 Dec; 286(51):43793-43808. PubMed ID: 21965678
[TBL] [Abstract][Full Text] [Related]
10. Restoration of mutant hERG stability by inhibition of HDAC6.
Li P; Kurata Y; Endang M; Ninomiya H; Higaki K; Taufiq F; Morikawa K; Shirayoshi Y; Horie M; Hisatome I
J Mol Cell Cardiol; 2018 Feb; 115():158-169. PubMed ID: 29355491
[TBL] [Abstract][Full Text] [Related]
11. Something about SUMO inhibits transcription.
Gill G
Curr Opin Genet Dev; 2005 Oct; 15(5):536-41. PubMed ID: 16095902
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.
Yang Y; Tse AK; Li P; Ma Q; Xiang S; Nicosia SV; Seto E; Zhang X; Bai W
Oncogene; 2011 May; 30(19):2207-18. PubMed ID: 21242980
[TBL] [Abstract][Full Text] [Related]
14. Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.
Blakeslee WW; Lin YH; Stratton MS; Tatman PD; Hu T; Ferguson BS; McKinsey TA
J Mol Cell Cardiol; 2017 Nov; 112():74-82. PubMed ID: 28886967
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
16. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
[TBL] [Abstract][Full Text] [Related]
17. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes.
Lugenbiel P; Govorov K; Rahm AK; Wieder T; Gramlich D; Syren P; Weiberg N; Seyler C; Katus HA; Thomas D
Cell Physiol Biochem; 2018; 49(1):65-77. PubMed ID: 30134221
[TBL] [Abstract][Full Text] [Related]
19. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
Schuetze KB; McKinsey TA; Long CS
J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
[TBL] [Abstract][Full Text] [Related]
20. Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human.
Wang D; Fang C; Zong NC; Liem DA; Cadeiras M; Scruggs SB; Yu H; Kim AK; Yang P; Deng M; Lu H; Ping P
Mol Cell Proteomics; 2013 Dec; 12(12):3793-802. PubMed ID: 24037710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
